Alkem Laboratories has denied allegations by the CDSCO that certain batches of its products, Pan-D and Clavam 625, failed to meet quality standards. The company asserted that the samples in question ...
The list has revealed that Pharma firm Alkem Health Science’s antibiotic drugs Clavam 625 and Pan D have been found spurious. (Image Credits: Pixabay) After the Central Drugs Standard Control ...
BENGALURU, Sept 27 (Reuters) - India's Alkem Laboratories (ALKE.NS), opens new tab on Friday denied claims that batches of its products, Pan-D and Clavam 625, are not of standard quality as the ...
New Delhi: Two months after a head constable received an input on a consignment of counterfeit medicines, a trap laid by the Delhi Police Crime Branch has taken the lid off a pan-India syndicate ...
The Indian Pharmaceutical Alliance (IPA) has defended its member companies after the Central Drug Standard Control Organisation (CDSCO) flagged 53 commonly used medicines for failing quality tests.
Select batches of popular and commonly used drugs, including the antacid Pan D, the anti-bacterial medicine Clavam 625, and the calcium supplement Shelcal, among basic medicines like paracetamol ...